ArticleEuropean heart journal2022

SGLT2 inhibitors DELIVER benefits in heart failure independently of ejection fraction and diabetes: end of the line or need for new studies?

Massimo Volpe et al.PubMed ↗Publisher ↗

No numbers read from the abstract.